Today’s article details two stocks that, according to both analysts at JPMorgan as well as the broader Wall Street analyst consensus, are primed for strong… Read More »2 Stocks Where Analysts See Strong Gains Ahead
FDA approval is the ultimate prize in the biotech industry – and one of the few major catalysts for biotech stocks. As a result, having… Read More »2 “Compelling” Biotech Stocks That Just Won The Ultimate Prize (FDA Approval)
As analysts unveil their top stock picks for 2020, it’s also worth examining how their top picks for 2019 ended up performing. Today’s article does… Read More »Assessing The Analysts: How Did Wall Street’s Top Stock Picks For 2019 Fare?
For marijuana stocks, a positive first quarter this year was not an indication of things to come as things started to take a turn for… Read More »Reversal Of Fortunes: 2019’s Important Lessons For Marijuana Stock Investors
What stocks are the most loved on Wall Street right now? Today’s article identifies the S&P 500 companies whose stocks currently have the highest percentage… Read More »Wall Street’s “Most-Loved” Stocks Right Now
In a further sign that marijuana has attained legitimacy on Wall Street, Merrill Lynch has initiated coverage on the sector in recent months – and… Read More »Merrill Lynch Is Most Positive On These 5 Pot Stocks
A recreational boat dealer, a small bank, and a manufacturer of tow trucks and car carriers with “no following on Wall Street whatsoever” are among… Read More »“Analytical Neglect” Could Make These 5 Stocks “Undiscovered Gems”
Which of the top cannabis stocks listed in the U.S. is the consensus favorite of Wall Street? Today’s article ranks the top “cannabis contenders” (including… Read More »Which Stock Wins Wall Street’s Battle Of The “Cannabis Contenders”?